In Silico Approaches for Predicting Adme Properties
暂无分享,去创建一个
[1] W. Stigelman,et al. Goodman and Gilman's the Pharmacological Basis of Therapeutics , 1986 .
[2] M. Schulz,et al. Therapeutic and toxic blood concentrations of more than 500 drugs. , 1997, Die Pharmazie.
[3] F. Lombardo,et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings , 1997 .
[4] S. Ekins,et al. Progress in predicting human ADME parameters in silico. , 2000, Journal of pharmacological and toxicological methods.
[5] Ana Martínez,et al. Prediction of Drug Half-life Values of Antihistamines Based on the CODES/Neural Network Model , 2000 .
[6] M. Medina-Hernández,et al. Retention pharmacokinetic and pharmacodynamic parameter relationships of antihistamine drugs using biopartitioning micellar chromatography. , 2001, Journal of chromatography. B, Biomedical sciences and applications.
[7] S. Agatonovic-Kustrin,et al. Molecular descriptors that influence the amount of drugs transfer into human breast milk. , 2002, Journal of pharmaceutical and biomedical analysis.
[8] Tingjun Hou,et al. ADME evaluation in drug discovery , 2002, Journal of molecular modeling.
[9] Stephen R. Johnson,et al. Molecular properties that influence the oral bioavailability of drug candidates. , 2002, Journal of medicinal chemistry.
[10] U. Norinder,et al. Computational approaches to the prediction of the blood-brain distribution. , 2002, Advanced drug delivery reviews.
[11] Gonzalo Colmenarejo,et al. In silico prediction of drug‐binding strengths to human serum albumin , 2003, Medicinal research reviews.
[12] Yi Li,et al. In silico ADME/Tox: why models fail , 2003, J. Comput. Aided Mol. Des..
[13] Mark T. D. Cronin,et al. A Hierarchical QSAR Model for Urinary Excretion of Drugs in Humans as a Predictive Tool for Biotransformation , 2003 .
[14] David A. Winkler,et al. Neural networks in ADME and toxicity prediction , 2004 .
[15] J. Duffy,et al. Prediction of Pharmacokinetic Parameters in Drug Design and Toxicology , 2004 .
[16] Franco Lombardo,et al. Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics. , 2004, Journal of medicinal chemistry.
[17] M. Cronin,et al. Quantitative structure‐pharmacokinetic relationship modelling: apparent volume of distribution , 2004, The Journal of pharmacy and pharmacology.
[18] Martin P. Payne,et al. Computer-Based Methods for the Prediction of Chemical Metabolism and Biotransformation within Biological Organisms , 2004 .
[19] Mark T. D. Cronin,et al. Predicting Chemical Toxicity and Fate , 2004 .
[20] J. V. Turner,et al. Pharmacokinetic parameter prediction from drug structure using artificial neural networks. , 2004, International journal of pharmaceutics.
[21] Zhi-Wei Cao,et al. Effect of Selection of Molecular Descriptors on the Prediction of Blood-Brain Barrier Penetrating and Nonpenetrating Agents by Statistical Learning Methods , 2005, J. Chem. Inf. Model..
[22] Scott D. Kahn,et al. Current Status of Methods for Defining the Applicability Domain of (Quantitative) Structure-Activity Relationships , 2005, Alternatives to laboratory animals : ATLA.
[23] Sean Ekins,et al. Computational prediction of human drug metabolism , 2005, Expert opinion on drug metabolism & toxicology.
[24] M T D Cronin,et al. Structure-Based Methods for the Prediction of the Dominant P450 Enzyme in Human Drug Biotransformation: Consideration of CYP3A4, CYP2C9, CYP2D6 , 2005, SAR and QSAR in environmental research.
[25] A. Ray,et al. In silico strategies for modeling membrane transporter function. , 2005, Drug discovery today.
[26] Ernesto Callegari,et al. A comprehensive listing of bioactivation pathways of organic functional groups. , 2005, Current drug metabolism.
[27] Huabei Zhang. A New Approach for the Tissue-Blood Partition Coefficients of Neutral and Ionized Compounds , 2005, J. Chem. Inf. Model..
[28] Miguel A. Cabrera,et al. A topological substructural approach for the prediction of P-glycoprotein substrates. , 2006, Journal of pharmaceutical sciences.
[29] T. Murakami,et al. Expression and function of efflux drug transporters in the intestine. , 2006, Pharmacology & therapeutics.
[30] Marcel J. de Groot,et al. Designing better drugs: predicting cytochrome P450 metabolism. , 2006 .
[31] Nigel J Waters,et al. Quantitative structure activity relationships in drug metabolism. , 2006, Current topics in medicinal chemistry.
[32] Anne Hersey,et al. Estimation of volume of distribution in humans from high throughput HPLC-based measurements of human serum albumin binding and immobilized artificial membrane partitioning. , 2006, Journal of medicinal chemistry.
[33] Judith C Madden,et al. Structure-based methods for the prediction of drug metabolism , 2006, Expert opinion on drug metabolism & toxicology.
[34] Wei Zhang,et al. Recent advances in computational prediction of drug absorption and permeability in drug discovery. , 2006, Current medicinal chemistry.
[35] Alexander Hillisch,et al. In Silico ADMET Traffic Lights as a Tool for the Prioritization of HTS Hits , 2006, ChemMedChem.
[36] Alexander Tropsha,et al. QSAR modeling of human serum protein binding with several modeling techniques utilizing structure-information representation. , 2006, Journal of medicinal chemistry.
[37] M. Abraham,et al. Air to brain, blood to brain and plasma to brain distribution of volatile organic compounds: linear free energy analyses. , 2006, European journal of medicinal chemistry.
[38] S C Basak,et al. Prediction of tissue: air partition coefficients — theoretical vs . experimental methods , 2006, SAR and QSAR in environmental research.
[39] M Paul Gleeson,et al. In silico human and rat Vss quantitative structure-activity relationship models. , 2006, Journal of medicinal chemistry.
[40] S. Ekins. Systems-ADME/Tox: resources and network approaches. , 2006, Journal of pharmacological and toxicological methods.
[41] M. Abraham,et al. A data base for partition of volatile organic compounds and drugs from blood/plasma/serum to brain, and an LFER analysis of the data. , 2006, Journal of pharmaceutical sciences.
[42] Z R Li,et al. Quantitative structure-pharmacokinetic relationships for drug clearance by using statistical learning methods. , 2006, Journal of molecular graphics & modelling.
[43] Matthew D. Segall,et al. ADMET Property Prediction: The State of the Art and Current Challenges , 2006 .
[44] D. Mills,et al. A quantitative structure–activity relationship (QSAR) study of dermal absorption using theoretical molecular descriptors , 2007, SAR and QSAR in environmental research.
[45] John C Dearden,et al. In silico prediction of ADMET properties: how far have we come? , 2007, Expert opinion on drug metabolism & toxicology.
[46] Sue Gibbs,et al. Xenobiotic metabolism in human skin and 3D human skin reconstructs: a review. , 2007, Current drug metabolism.
[47] Lars Carlsson,et al. State-of-the-art Tools for Computational Site of Metabolism Predictions: Comparative Analysis, Mechanistical Insights, and Future Applications , 2007, Drug metabolism reviews.
[48] Tingjun Hou,et al. ADME Evaluation in Drug Discovery, 7. Prediction of Oral Absorption by Correlation and Classification , 2007, J. Chem. Inf. Model..
[49] Ursula Gundert-Remy,et al. Physiologically-based Kinetic Modelling (PBK Modelling): Meeting the 3Rs Agenda , 2007, Alternatives to laboratory animals : ATLA.
[50] Han van de Waterbeemd,et al. Time‐Series QSAR Analysis of Human Plasma Protein Binding Data , 2007 .
[51] J C Madden,et al. Structure-based modelling in reproductive toxicology: (Q)SARs for the placental barrier , 2007, SAR and QSAR in environmental research.
[52] Yiyu Cheng,et al. Identifying P-Glycoprotein Substrates Using a Support Vector Machine Optimized by a Particle Swarm , 2007, J. Chem. Inf. Model..
[53] Tingjun Hou,et al. ADME Evaluation in Drug Discovery, 6. Can Oral Bioavailability in Humans Be Effectively Predicted by Simple Molecular Property-Based Rules? , 2007, J. Chem. Inf. Model..
[54] Adriano D Andricopulo,et al. Hologram QSAR model for the prediction of human oral bioavailability. , 2007, Bioorganic & medicinal chemistry.
[55] Mark L. Lewis,et al. Predicting Penetration Across the Blood-Brain Barrier from Simple Descriptors and Fragmentation Schemes , 2007, J. Chem. Inf. Model..
[56] Yvan Vander Heyden,et al. Benchmarking of QSAR Models for Blood-Brain Barrier Permeation , 2007, J. Chem. Inf. Model..
[57] Balázs Sarkadi,et al. The role of ABC transporters in drug absorption, distribution, metabolism, excretion and toxicity (ADME-Tox). , 2008, Drug discovery today.
[58] Edward H. Kerns,et al. Drug-like Properties: Concepts, Structure Design and Methods: from ADME to Toxicity Optimization , 2008 .
[59] J C Madden,et al. An evaluation of global QSAR models for the prediction of the toxicity of phenols to Tetrahymena pyriformis. , 2008, Chemosphere.
[60] Xin Wu,et al. Predicting the volume of distribution of drugs in humans. , 2008, Current drug metabolism.
[61] M. Gleeson. Generation of a set of simple, interpretable ADMET rules of thumb. , 2008, Journal of medicinal chemistry.
[62] Lujia Han,et al. An evaluation of mathematical models for predicting skin permeability. , 2008, Journal of pharmaceutical sciences.
[63] Kairui Feng,et al. The Simcyp® Population-based ADME Simulator , 2009 .